Quest Diagnostics Inc. (DGX)
Quest Diagnostics Inc. reported revenue of $11.04B for the fiscal year ended Dec 31, 2025, up 11.8% from $9.87B the year before. Net income was $992.00M, a net margin of 9.0% (prior year: $871.00M). At the end of that fiscal year the company reported total assets of $16.23B and shareholders' equity of $7.17B.
Revenue
$11.04B
+11.8% vs prior year
Net income
$992.00M
Net margin 9.0%
Diluted EPS
$8.75
USD per share
Total assets
$16.23B
At Dec 31, 2025
Equity
$7.17B
At Dec 31, 2025
Shares outstanding
110M
As of Oct 15, 2026
Explore Quest Diagnostics Inc.'s filings
- Revenue by year — annual and quarterly revenue with growth rates
- Income statement & cash flow — profit, margins, EPS and operating cash flow
- Balance sheet — assets, liabilities, equity, cash and debt
- SEC filings — 10-K and 10-Q filings with links to EDGAR
Latest SEC filings
- 10-QFiled Oct 23, 2026
- 10-QFiled Jul 23, 2026
- 10-QFiled Apr 22, 2026
- 10-KFiled Feb 26, 2026
- 10-QFiled Oct 21, 2025
- 10-QFiled Jul 23, 2025
Source: SEC EDGAR XBRL company facts for CIK 1022079 (raw data). Most recent filing in this dataset: 10-Q filed Oct 23, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.